Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
44,542,200
-
Number of holders
-
34
-
Total 13F shares, excl. options
-
10,531,506
-
Shares change
-
-7,585
-
Total reported value, excl. options
-
$134,807,000
-
Value change
-
-$160,970
-
Number of buys
-
11
-
Number of sells
-
-13
-
Price
-
$12.8
Significant Holders of TELA Bio, Inc. - Common Stock, par value $0.001 per share (TELA) as of Q4 2021
38 filings reported holding TELA - TELA Bio, Inc. - Common Stock, par value $0.001 per share as of Q4 2021.
TELA Bio, Inc. - Common Stock, par value $0.001 per share (TELA) has 34 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 10,531,506 shares
of 44,542,200 outstanding shares and own 23.64% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (3,027,542 shares), Essex Woodlands Management, Inc. (1,906,228 shares), RTW INVESTMENTS, LP (1,399,686 shares), PURA VIDA INVESTMENTS, LLC (564,120 shares), Opaleye Management Inc. (449,867 shares), COWEN AND COMPANY, LLC (434,033 shares), SILVERCREST ASSET MANAGEMENT GROUP LLC (392,975 shares), ARMISTICE CAPITAL, LLC (348,000 shares), VANGUARD GROUP INC (347,935 shares), and Pentwater Capital Management LP (312,238 shares).
This table shows the top 34 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.